Comparison of IVF-ET outcomes with GnRH antagonist started either on stimulation day 1 and 6 vs. conventional GnRH agonist long protocol in patients with polycystic ovary syndrome
Not Applicable
Recruiting
- Conditions
- Endocrine, nutritional and metabolic disease
- Registration Number
- KCT0000157
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 267
Inclusion Criteria
PCOS patients (diagnosed as 2003 ASRM/ESHRE consensus meeting guideline)
age 20-40 years
patients who have normal uterus
Exclusion Criteria
patients who have abnormal thyroid function
patients who have abnormal prolactin test
patients who have diabetes, or Cushing's syndrome, or congenital adrenal hyperplasia, or androgen-producing tumor.
Patients who reject informed consent
patients who have experience of adverse events for GnRH agonist, antagonist, recombinant FSH.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method number of oocyte retrieved
- Secondary Outcome Measures
Name Time Method pregnancy rate